277 related articles for article (PubMed ID: 25993220)
1. Neoadjuvant therapy for melanoma: a promising therapeutic approach and an ideal platform in drug development.
Tarhini AA
Am Soc Clin Oncol Educ Book; 2015; ():e535-42. PubMed ID: 25993220
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy of locally/regionally advanced melanoma.
Khunger A; Buchwald ZS; Lowe M; Khan MK; Delman KA; Tarhini AA
Ther Adv Med Oncol; 2019; 11():1758835919866959. PubMed ID: 31391869
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant therapy for high-risk bulky regional melanoma.
Tarhini AA; Pahuja S; Kirkwood JM
J Surg Oncol; 2011 Sep; 104(4):386-90. PubMed ID: 21858833
[TBL] [Abstract][Full Text] [Related]
4. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
McKean MA; Amaria RN
Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.
Davar D; Tarhini AA; Kirkwood JM
Clin Dermatol; 2013; 31(3):237-50. PubMed ID: 23608443
[TBL] [Abstract][Full Text] [Related]
6. Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
Indini A; Roila F; Grossi F; Massi D; Mandalà M
Am J Clin Dermatol; 2021 Jul; 22(4):511-522. PubMed ID: 34036489
[TBL] [Abstract][Full Text] [Related]
7. How to use neoadjuvant medical treatment to maximize surgery in melanoma.
Amaral T; Tampouri I; Garbe C
Expert Rev Anticancer Ther; 2018 Feb; 18(2):121-130. PubMed ID: 29271674
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives.
Testori AAE; Ribero S; Indini A; Mandalà M
Am J Clin Dermatol; 2019 Dec; 20(6):817-827. PubMed ID: 31177507
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Therapy for Melanoma.
Lowe MC; Kudchadkar RR
Surg Oncol Clin N Am; 2020 Jul; 29(3):445-453. PubMed ID: 32482319
[TBL] [Abstract][Full Text] [Related]
10. Melanoma adjuvant therapy.
Tarhini AA; Thalanayar PM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
[TBL] [Abstract][Full Text] [Related]
11. (Neo)adjuvant systemic therapy for melanoma.
van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
[TBL] [Abstract][Full Text] [Related]
13. News from the melanoma sessions of the European Cancer Congress 2017.
Rutkowski P; Kozak K
BMC Med; 2017 Mar; 15(1):57. PubMed ID: 28302128
[TBL] [Abstract][Full Text] [Related]
14. Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy.
Tarhini AA; Lorigan P; Leachman S
Am Soc Clin Oncol Educ Book; 2017; 37():651-660. PubMed ID: 28561661
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
McKean MA; Amaria RN
Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F; Croce E; Boutros A; Tanda E; Cecchi F; Mascherini M; Solari N; Cafiero F; Queirolo P
Expert Rev Anticancer Ther; 2020 May; 20(5):403-413. PubMed ID: 32326767
[No Abstract] [Full Text] [Related]
17. Neoadjuvant immunotherapy of locoregionally advanced solid tumors.
Tarhini AA; Eads JR; Moore KN; Tatard-Leitman V; Wright J; Forde PM; Ferris RL
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35973745
[TBL] [Abstract][Full Text] [Related]
18. [Melanoma update].
Longvert C; Saiag P
Rev Med Interne; 2019 Mar; 40(3):178-183. PubMed ID: 30527396
[TBL] [Abstract][Full Text] [Related]
19. State of melanoma: an historic overview of a field in transition.
Gorantla VC; Kirkwood JM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):415-35. PubMed ID: 24880939
[TBL] [Abstract][Full Text] [Related]
20. Melanoma: from darkness to promise.
Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
